Publication: « Molecular and clinical diversity in primary central nervous system lymphoma »
Learn moreVideo: the new challenges of CAR-T cells
Learn moreCURAMUS supports the 3rd national OncoNeuroTox scientific day
Learn moreCURAMUS will participate to the "Fête de la Science" 2022 !
Learn moreCall for applications for the renewal of the Health Democracy Committee from the French National Cancer Institute
Learn more🎞 Video
Learn moreCuramus, l'un des 8 sites de recherche translationnelle sur le cancer
Learn more🎞 Video
Learn moreSiRIC Curamus presentation
Learn moreSupport Curamus
Learn more
Our ambition is to accelerate research on cancers that are particularly difficult to treat through the development of diagnostic and therapeutic innovations to benefit patients as quickly as possible and thus improve their care and follow-up. We are counting on your support.
Director of Curamus
SiRIC CURAMUS
Cancer United Research Associating Medicine, University & Society
Curamus is one of the eight integrated cancer research sites (SiRIC), certified by the National Cancer Institute (INCa), the Ministry of Solidarity and Health, Inserm and ITMO Cancer AVIESAN (National Alliance for Life Sciences and Health). The SIRIC Curamus aims to bring together and promote the synergy of its multidisciplinary teams around the AP-HP.SORBONNE UNIVERSITY hospital-university group in order to accelerate research and innovation in cancerology to improve care for the benefit of patients.
Curamus is supported by the AP-HP.Sorbonne University Hospital Group and by the 3 faculties of Medicine, Engineering Sciences and Literature of the Sorbonne University under the federation of the University Institute of Cancerology (IUC), in association with their institutional partners, Inserm and CNRS.
Our research programs
Our transversal programs
Follow the activity of CURAMUS
Stay informed about translational and clinical research in SiRIC CURAMUS
SAVE THE DATE: Brain Tumor Microenvironment Symposium, 30th & 31st January 2025, Paris
Within the framework of the integrated research program “Brain, cancer and immunity – cellular crosstalk in brain tumors”, the SiRIC […]
📚 Publication: « Molecular and clinical diversity in primary central nervous system lymphoma »
Primary cerebral lymphoma: a new classification of the disease aimed at improving the lives of patients HERNANDEZ Isaïas, doctoral student; […]
🎞 Video: the new challenges of CAR-T cells
CAR-T cells are a new type of therapy that offers high hopes for cancer fighting. With this video, the SiRIC […]
📖 Project « Trials of Damocles » publication
In 2019, a SiRIC CURAMUS interdisciplinary team led by Marie-Pierre Dann, specialised clinical nurse (Hematology Department of the Pitié-Salpêtrière Hospital) […]
📢 INCa general public conference “Live and work with a cancer”
As part of the “Cancer and Employment” meetings, the French National Cancer Institute organizes on the 22th November 2022 a general […]
){kind=icon}
)
){kind=logo}
){kind=logo}